Sort
21,453 grants matching “tuberculosis”
TUBERCULOSIS CONTROL PROGRAM AND AIDS
$827,342Julia Moore · Cabinet For Health And Family Services · U52 · FY2009 · PS
TUBERCULOSIS CONTROL PROGRAM AND AIDS
$827,262Robert L. Brawley · Cabinet For Health And Family Services · U52 · FY2008 · PS
A Preclinical Program for Targeting Mycobacterium tuberculosis KasA
$826,401Joel Stephen Freundlich · Rbhs-New Jersey Medical School · R01 · FY2021 · AI
ROLE OF INDUCIBLE BRONCHUS ASSOCIATED LYMPHOID TISSUE IN LATENT TUBERCULOSIS
$826,347Shabaana A. Khader · Washington University · R01 · FY2015 · AI
Defining the Immunogenicity and Efficacy of a Durable BCG Vaccine Strategy Optimized for Preventing TB in Pediatric HIV Infection
$826,203Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI
AIDS International Training and Research Program
$826,030Warren D. Johnson · Weill Medical Coll Of Cornell Univ · D43 · FY2008 · TW
Lesion-centric optimization of multidrug therapies for tuberculosis
$823,212Bree Beardsley Aldridge · Tufts University Boston · R01 · FY2023 · AI
Genes/Pathways for ATG Gene-dependent Inhibition of Viruses & Parasite Infection
$822,472Herbert W Virgin · Washington University · U19 · FY2015 · AI
Promoting Adherence to TB Regimens in High-Risk Youth
$822,417San Diego State University · R01 · FY2004 · HL
Sequencing Core
$822,385James C Sacchettini · Harvard Medical School · U19 · FY2014 · AI
Perturbation of antigen-specific T cell responses in latent TB/SIV co-infection
$822,232Deepak Kaushal · Tulane University Of Louisiana · R01 · FY2018 · AI
Screening Complete TB Proteome for Protective Antigens
$822,028Alan Greener · Gene Therapy Systems, Inc. · R44 · FY2006 · AI
Tuberculosis infection and risk of diabetes mellitus and cardiovascular disease: Epigenetic and cardiometabolic trajectories after TB infection
$821,087Matthew James Magee · Emory University · R01 · FY2025 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$820,866Kristen R Ehreshmann · Minnesota State Dept Of Health · U52 · FY2007 · PS
DYNAMICS AND TUNING OF THE MHC II PRESENTED PEPTIDOME
$820,429Laura Santambrogio · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · AI
Esx5 secretome in TB and TB-HIV pathogenesis and immunity
$820,246William Robert Jacobs · Albert Einstein College Of Medicine · R01 · FY2025 · AI
Targeting Biotin Metabolism in Mycobacterium Tuberculosis
$820,039Courtney C Aldrich · University Of Minnesota · R01 · FY2019 · AI
Using proteomics to identify host cell death factors during M. tuberculosis infection
$819,998Jonathan M Budzik · University Of California, San Francisco · R01 · FY2025 · AI
Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology
$818,507Brianna Mullins · Salus Discovery, Llc · R44 · FY2024 · HD
Gene Regulation In The Immune System
$818,475Keiko Ozato · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2014 · HD
NK cell-mediated regulation of T cell immunity in TB/HIV co-infection
$818,412Cheryl Liane Day · Emory University · R01 · FY2017 · AI
Lesion-centric optimization of multidrug therapies for tuberculosis
$818,294Bree Beardsley Aldridge · Tufts University Boston · R01 · FY2024 · AI
Pro-apoptotic Drugs as Host-Directed Treatments for Pulmonary Tuberculosis
$817,941Sanjay Jain · Johns Hopkins University · R56 · FY2024 · AI
Host biomarkers for M. tuberculosis infection activity in HIV-infected persons
$817,851Jacqueline Michele Achkar · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · AI
Inhalational therapy with spectinamides within new regimens of TB therapy
$817,405Mercedes Gonzalez-Juarrero · Colorado State University · R01 · FY2024 · AI